Short term use of octreotide in acromegaly.
A 44-year gentleman with acromegaly underwent transphenoidal excision of pituitary macroadenoma followed by radiotherapy. Since he had poor glycemic control necessitating multiple insulin doses, he was started on subcutaneous octreotide. With this, his blood sugars came under control rapidly and insulin could be withdrawn fully. This case report highlights the use of octreotide in a specific clinical situation in acromegaly to improve the quality of life.
John
M
M
Department of Endocrinology, Seth GS Medical College and KEM Hospital, Mumbai.
Shah
Nalini S
NS
Menon
Padma S
PS
D000172:Acromegaly / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D019382:Human Growth Hormone / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D013997:Time Factors
D018931:Antineoplastic Agents, Hormonal; D019382:Human Growth Hormone; D015282:Octreotide